# Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain

> **NCT02293525** · NA · WITHDRAWN · sponsor: **Vital 5, LLC**

## Conditions studied

- Low Back Pain

## Interventions

- **DEVICE:** ReLeaf catheter
- **DRUG:** Ropivacaine
- **DRUG:** Saline
- **DRUG:** Morphine
- **DRUG:** Oxycodone

## Key facts

- **NCT ID:** NCT02293525
- **Lead sponsor:** Vital 5, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No subjects were enrolled and the sponsor suspended support at this time
- **Last updated:** 2016-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293525, "Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02293525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*